Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Z Geburtshilfe Neonatol ; 213(3): 89-95, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19536708

RESUMEN

BACKGROUND AND PURPOSE: Preeclampsia is a major obstetric problem of unknown etiology. The fact that removal of the placenta is the only cure for preeclampsia, has led to the well-established hypothesis, that the placenta is central in the etiology. Gene profiling and proteomics studies have suggested oxidative stress caused by reperfusion and free oxygen radicals as a potential pathophysiological mechanism in preeclampsia. In this study, the dual placental perfusion model was used in order to evaluate the damaging effects of oxidative stress induced by xanthine/xanthine oxides and free hemoglobin. MATERIAL AND METHODS: The dual placenta perfusion model is a well-established in vitro model for functional placental studies. Placentas were perfused with medium containing either xanthine/xanthine oxidase or erythrocytes as a source of free hemoglobin. Concentration of free hemoglobin in the medium was measured by means of ELISA. Whole genome microarray technique and bioinformatics were used to evaluate the gene expression profile in the two groups. RESULTS: Substantial levels of free adult hemoglobin were detected in the perfusions. A total of 58 genes showed altered gene expression, the most altered were hemoglobin alpha, beta and gamma, tissue factor pathway inhibitor 2 and superoxide dismutase 2. Bioinformatics revealed that biological processes related to oxidative stress, anti-apoptosis and iron ion binding were significantly altered. CONCLUSIONS: The results suggest that perfusion with xanthine/xanthine oxidase and free hemoglobin induce changes in gene expression similar to what has been described for the preeclamptic placenta.


Asunto(s)
Eritrocitos/metabolismo , Eritrocitos/patología , Modelos Biológicos , Placenta/metabolismo , Preeclampsia/metabolismo , Preeclampsia/patología , Xantina Oxidasa/metabolismo , Adulto , Femenino , Humanos , Técnicas In Vitro , Perfusión/métodos , Embarazo , Xantina Oxidasa/administración & dosificación
2.
APMIS ; 103(5): 395-400, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7654364

RESUMEN

Zinc deficiency impairs connective tissue contraction in the perforated rat mesentery model. Since the rat mesentery is almost avascular, free peritoneal macrophages are important for mesenteric repair. Impairment of contraction may thus be caused either by a direct effect of zinc deficiency on tissue cells or by hampered macrophage function. To further elucidate the role of macrophages in tissue contraction, we studied their effect on lattice contraction. A number of typical functions of macrophages in zinc deficiency were also investigated. Lattice contraction was significantly impaired by conditioned medium from zinc-deficient macrophages. Zinc deficiency did not influence peripheral blood leukocyte number, but postoperatively the number of peritoneal macrophages increased on days 7 and 10. A significant release of lysosomal enzymes from macrophages was recorded during phagocytosis, whilst no difference was observed between controls and zinc-deficient macrophages. Superoxide anion generation during phagocytosis was not significantly increased in zinc deficiency. Conditioned medium from zinc-deficient macrophages was shown to impair lattice contraction in vitro and the results are compatible with impaired macrophage function as a cause of decreased connective tissue contraction in vivo.


Asunto(s)
Colágeno/fisiología , Tejido Conectivo/fisiología , Macrófagos/fisiología , Mesenterio/fisiología , Zinc/deficiencia , Acetilglucosaminidasa/metabolismo , Animales , Degranulación de la Célula , Masculino , Ratas , Ratas Sprague-Dawley , Procedimientos Quirúrgicos Operativos , beta-Galactosidasa/metabolismo
3.
Placenta ; 33 Suppl: S42-7, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22197626

RESUMEN

Worldwide the prevalence of preeclampsia (PE) ranges from 3 to 8% of pregnancies. 8.5 million cases are reported yearly, but this is probably an underestimate due to the lack of proper diagnosis. PE is the most common cause of fetal and maternal death and yet no specific treatment is available. Reliable biochemical markers for prediction and diagnosis of PE would have a great impact on maternal health and several have been suggested. This review describes PE biochemical markers in general and first trimester PE biochemical markers specifically. The main categories described are angiogenic/anti-angiogenic factors, placental proteins, free fetal hemoglobin (HbF), kidney markers, ultrasound and maternal risk factors. The specific biochemical markers discussed are: PAPP-A, s-Flt-1/PlGF, s-Endoglin, PP13, cystatin-C, HbF, and α1-microglobulin (A1M). PAPP-A and HbF both show potential as predictive biochemical markers in the first trimester with 70% sensitivity at 95% specificity. However, PAPP-A is not PE-specific and needs to be combined with Doppler ultrasound to obtain the same sensitivity as HbF/A1M. Soluble Flt -1 and PlGF are promising biochemical markers that together show high sensitivity from the mid-second trimester. PlGF is somewhat useful from the end of the first trimester. Screening pregnant women with biochemical markers for PE can reduce unnecessary suffering and health care costs by early detection of mothers at increased risk for PE, thus avoiding unnecessary hospitalization of pregnant women with suspect or mild PE and enabling monitoring of the progression of the disease thereby optimizing time for delivery and hopefully reducing the number of premature births.


Asunto(s)
Tamizaje Masivo/métodos , Preeclampsia/diagnóstico , Preeclampsia/fisiopatología , Animales , Biomarcadores/sangre , Biomarcadores/orina , Diagnóstico Precoz , Femenino , Humanos , Preeclampsia/epidemiología , Preeclampsia/metabolismo , Valor Predictivo de las Pruebas , Embarazo , Proteínas Gestacionales/sangre , Proteínas Gestacionales/orina , Primer Trimestre del Embarazo , Factores de Riesgo , Índice de Severidad de la Enfermedad
4.
Placenta ; 32(4): 323-32, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21356557

RESUMEN

BACKGROUND: Preeclamptic women have increased plasma levels of free fetal hemoglobin (HbF), increased gene expression of placental HbF and accumulation of free HbF in the placental vascular lumen. Free hemoglobin (Hb) is pro-inflammatory, and causes oxidative stress and tissue damage. METHODOLOGY: To show the impact of free Hb in PE, we used the dual ex vivo placental perfusion model. Placentas were perfused with Hb and investigated for physical parameters, Hb leakage, gene expression and morphology. The protective effects of α(1)-microglobulin (A1M), a heme- and radical-scavenger and antioxidant, was investigated. RESULTS: Hb-addition into the fetal circulation led to a significant increase of the perfusion pressure and the feto-maternal leakage of free Hb. Morphological damages similar to the PE placentas were observed. Gene array showed up-regulation of genes related to immune response, apoptosis, and oxidative stress. Simultaneous addition of A1M to the maternal circulation inhibited the Hb leakage, morphological damage and gene up-regulation. Furthermore, perfusion with Hb and A1M induced a significant up-regulation of extracellular matrix genes. SIGNIFICANCE: The ex vivo Hb-perfusion of human placenta resulted in physiological and morphological changes and a gene expression profile similar to what is observed in PE placentas. These results underline the potentially important role of free Hb in PE etiology. The damaging effects were counteracted by A1M, suggesting a role of this protein as a new potential PE therapeutic agent.


Asunto(s)
alfa-Globulinas/uso terapéutico , Hemoglobinas/farmacología , Placenta/efectos de los fármacos , Preeclampsia/prevención & control , Femenino , Hemoglobina Fetal/metabolismo , Hemoglobina Fetal/farmacología , Perfilación de la Expresión Génica , Hemoglobinas/metabolismo , Humanos , Técnicas In Vitro , Estrés Oxidativo , Perfusión , Placenta/metabolismo , Preeclampsia/sangre , Embarazo , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda